Taking on breast cancer in East Africa: Global challenges in breast cancer

Current Opinion in Obstetrics and Gynecology

Volumn 27, Issue 1, 2015, Pages 108-114

  Kantelhardt, Eva Johanna ^a   Cubasch, Herbert ^b,c   Hanson, Claudia ^d,e  

^a Università Tsklinikum Halle   (Germany)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d KAROLINSKA INSTITUTE   (Sweden)

^e IFAKARA HEALTH INSTITUTE   (Tanzania)

Author keywords

Africa; breast neoplasms; incidence; risk factors

Indexed keywords

ESTROGEN RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AFRICA; AFRICAN; AWARENESS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; DISTANT METASTASIS FREE SURVIVAL; EARLY DIAGNOSIS; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; INFLAMMATORY BREAST CANCER; MAMMOGRAPHY; METASTASIS FREE SURVIVAL; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; BREAST NEOPLASMS; CONTROLLED STUDY; DEVELOPING COUNTRY; EPIDEMIOLOGY; HEALTH CARE DELIVERY; HEALTH SURVEY; INCIDENCE; MASTECTOMY; MORTALITY; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL; REGISTER; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AFRICA, EASTERN; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE RATIONING; HUMANS; INCIDENCE; MAMMOGRAPHY; MASTECTOMY; POPULATION SURVEILLANCE; REFERRAL AND CONSULTATION; REGISTRIES;

EID: 84920755987     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000139     Document Type: Review

References (51)

1. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11:165-173.
2. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triplenegative breast cancer. J Clin Oncol 2009; 27:4515-4521.
3. United Nations. Report of the Formal Meeting of Member States to conclude the work on the comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of NCD; 2014.
4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11; 2013. http://globocan.iarc.fr.
5. Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa. Cancer Epidemiol Biomarkers Prev 2014; 23:953-966.
6. Chokunonga E, Borok MZ, Chirenje ZM, et al. Trends in the incidence of cancer in the black population of Harare Zimbabwe. Int J Cancer 2013; 133:721-729.
7. Wabinga HR, Nambooze S, Amulen PM, et al. Trends in the incidence of cancer in Kampala, Uganda. Int J Cancer 2014; 135:432-439.
8. Brinton LA, Figueroa JD, Awuah B, et al. Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat 2014; 144:467-478.
9. African Cancer Registry Network; 2014. www.afcrn.org.
10. McCormack VA, Joffe M, van den Berg E, et al. Breast cancer receptor status and stage at diagnosis in over 1, 200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res 2013; 15:R84.
11. Galukande M, Wabinga H, Mirembe F, et al. Difference in risk factors for breast cancer by ER status in an indigenous African population. ISRN Oncol 2013; 2013:463594.
12. Sayed S, Moloo Z, Wasike R, et al. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya. Breast 2014; 23:591-596.
13. Adjei EK, Owusu-Afriyie O, Awuah B, Stalsberg H. Hormone receptors and Her2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway. Breast J 2014; 20:308-311.
14. Jemal A, Fedewa SA. Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women? Breast Cancer Res Treat 2012; 135:867-873.
15. Oluwagbemiga LA, Oluwole A, Kayode AA. Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? A systematic review. Springerplus 2012; 1:83.
16. Laraqui A, Uhrhammer N, Lahlou-Amine I, et al. Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population. Int J Med Sci 2013; 10:60-67.
17. Biunno I, Aceto G, Awadelkarim KD, et al. BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan. Fam Cancer 2014. http://link. springer.com/article/10.1007%2Fs10689-014-9717-4.
18. Hagag E, Shwaireb M, Coffa J, El Wakil A. Screening for BRCA1 large genomic rearrangements in female Egyptian hereditary breast cancer patients. East Mediterr Health J 2013; 19:255-262.
19. Hou N, Ogundiran T, Ojengbede O, et al. Risk factors for pregnancyassociated breast cancer: a report from the Nigerian Breast Cancer Study. Ann Epidemiol 2013; 23:551-557.
20. Gomez F, Hirbo J, Tishkoff SA. Genetic variation and adaptation in Africa: implications for human evolution and disease. Cold Spring Harb Perspect Biol 2014; 6:a008524.
21. Schoeman M, Apffelstaedt JP, Baatjes K, Urban M. Implementation of a breast cancer genetic service in South Africa: lessons learned. S Afr Med J 2013; 103:529-533.
22. Marshall PA, Adebamowo CA, Adeyemo AA, et al. Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria. BMC Med Ethics 2014; 15:38.
23. Abuidris DO, Elsheikh A, Ali M, et al. Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study. Lancet Oncol 2013; 14:363-370.
24. Dickens C, Joffe M, Jacobson J, et al. Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1, 000 women. Int J Cancer 2014; 135:2173-2182.
25. Frikha M, Yaiche O, Elloumi F, et al. Results of a pilot study for breast cancer screening by mammography in Sfax region, Tunisia. J Gynecol Obstet Biol Reprod (Paris) 2013; 42:252-261.
26. Peltzer K, Phaswana-Mafuya N. Breast and cervical cancer screening and associated factors among older adult women in South Africa. Asian Pac J Cancer Prev 2014; 15:2473-2476.
27. Zelle SG, Baltussen RM. Economic analyses of breast cancer control in low-and middle-income countries: a systematic review. Syst Rev 2013; 2:20.
28. Kantelhardt EJ, Zerche P, Mathewos A, et al. Breast cancer survival in Ethiopia: a cohort study of 1, 070 women. Int J Cancer 2014; 135:702-709.
29. Bouzid N, Lahmar R, Tebra S, Bouaouina N. Breast cancer in woman younger than 35 years in Tunisia: retrospective study about 124 cases. Gynecol Obstet Fertil 2013; 41:356-360.
30. Mody GN, Nduaguba A, Ntirenganya F, Riviello R. Characteristics and presentation of patients with breast cancer in Rwanda. Am J Surg 2013; 205:409-413.
31. Tesfamariam A, Gebremichael A, Mufunda J. Breast cancer clinicopathological presentation, gravity and challenges in Eritrea, East Africa: management practice in a resource-poor setting. S Afr Med J 2013; 103:526-528.
32. Edmund DM, Naaeder SB, Tettey Y, Gyasi RK. Breast cancer in Ghanaian women: what has changed? Am J Clin Pathol 2013; 140:97-102.
33. Corbex M, Bouzbid S, Boffetta P. Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer 2014; 50:1808-1818.
34. Schairer C, Soliman AS, Omar S, et al. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. Cancer Med 2013; 2:178-184.
35. Cubasch H, Joffe M, Hanisch R, et al. Breast cancer characteristics and HIV among 1, 092 women in Soweto, South Africa. Breast Cancer Res Treat 2013; 140:177-186.
36. Msolly A, Gharbi O, BenAhmed S. Impact ofmenstrual and reproductive factors on breast cancer risk in Tunisia: a case-control study.MedOncol2013; 30:480.
37. Sighoko D, Kamate B, Traore C, et al. Breast cancer in premenopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life. Breast 2013; 22:828-835.
38. Jordan I, Hebestreit A, Swai B, Krawinkel MB. Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania. Breast Cancer Res Treat 2013; 142:133-141.
39. Ogundiran TO, Ayandipo OO, Ademola AF, Adebamowo CA. Mastectomy for management of breast cancer in Ibadan, Nigeria. BMC Surg 2013; 13:59.
40. Arowolo OA, Njiaju UO, Ogundiran TO, et al. Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study. Breast J 2013; 19:470-477.
41. Abdel-Wahab M, Bourque J, Pynda Y, et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol 2013; 14:e168-e175.
42. Williams CK, Cristina Stefan D, Rawlinson F, et al. The African Organisation for Research and Training in Cancer and its conferences: a historical perspective and highlights of the Ninth International Conference, Durban, South Africa, 21-24 November 2013. Ecancermedicalscience 2014; 8:396.
43. Braun G, Fuhrer A, Breitenstein E, et al. Cancer in Africa: AORTIC 8th International Cancer Conference Entering the 21st Century for Cancer Control in Africa 30.11-2 12. 2011. Breast Care (Basel) 2012; 7:177-179.
44. Breast Health Global Initiative. The Breast HealthGlobal Initiative [cited 1 Aug 2014]. http://portal.bhgi.org/Pages/Default.aspx.
45. Cardoso F, Bese N, Distelhorst SR, et al. Supportive care during treatment for breast cancer: resource allocations in low-and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22:593-605.
46. Ganz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low-and middleincome countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22:606-615.
47. Cleary J, Ddungu H, Distelhorst SR, et al. Supportive and palliative care for metastatic breast cancer: resource allocations in low-and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013; 22:616-627.
48. Koon KP, Lehman CD, Gralow JR. The importance of survivors and partners in improving breast cancer outcomes in Uganda. Breast 2013; 22:138-141.
49. UICC. Union for Internationl Cancer Control [cited 1 Aug 2014]. http://www.uicc.org/.
50. IARC. International Agency for Research on Cancer; 2014. http://www. iarc.fr/.
51. The H3 Africa Consortium. Research capacity. Enabling the genomic revolution in Africa. Science 2014; 344:1346-1348.